Garrett R. Rettig
Integrated DNA Technologies (United States)(US)
Publications by Year
Research Areas
CRISPR and Genetic Engineering, Advanced biosensing and bioanalysis techniques, CAR-T cell therapy research, Virus-based gene therapy research, RNA Interference and Gene Delivery
Most-Cited Works
- → A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells(2018)782 cited
- → Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells(2020)275 cited
- → Progress Toward In Vivo Use of siRNAs-II(2011)216 cited
- → Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease(2025)211 cited
- → Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes(2017)157 cited
- → Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair(2021)113 cited
- → Potency of siRNA versus shRNA mediated knockdown in vivo(2007)91 cited
- → Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells(2021)81 cited
- → Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System(2020)69 cited
- → Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo(2013)57 cited